A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation

Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma

NCT00705874 ·Status: COMPLETED ·Phase: PHASE1

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

NCT01247337 ·Status: COMPLETED ·Phase: PHASE2

A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer

NCT00448734 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Clinical Studies of Gemcitabine-Oxaliplatin

NCT00407433 ·Status: COMPLETED ·Phase: PHASE2

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

NCT00667641 ·Status: COMPLETED ·Phase: PHASE1

Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

NCT01633645 ·Status: COMPLETED ·Phase: PHASE2

Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors

NCT00874042 ·Status: COMPLETED ·Phase: PHASE1

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00243100 ·Status: COMPLETED ·Phase: PHASE1

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

NCT03943043 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

NCT00142467 ·Status: COMPLETED ·Phase: PHASE2

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

NCT04265274 ·Status: WITHDRAWN ·Phase: PHASE2

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

NCT00003518 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy In Treating Patients With Advanced Cancer

NCT00003925 ·Status: COMPLETED ·Phase: PHASE1

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT00003742 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

NCT03314935 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment

NCT01262482 ·Status: COMPLETED ·Phase: PHASE2

Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC

NCT03478488 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00004242 ·Status: COMPLETED ·Phase: PHASE1

Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer

NCT00171587 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

NCT00473720 ·Status: COMPLETED ·Phase: PHASE1

Combination Chemotherapy for Metastatic Breast Cancer

NCT00191815 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen

NCT01497470 ·Status: COMPLETED ·Phase: PHASE1

An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer

NCT01442155 ·Status: COMPLETED

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

NCT04679012 ·Status: RECRUITING ·Phase: PHASE2

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

NCT00009815 ·Status: WITHDRAWN ·Phase: PHASE1